The content of this report will be updated with the latest scenarios based on the global COVID-19 Pandemic
The Europe Contrast Media Market would witness market growth of 3.13% CAGR during the forecast period (2019-2025).
The Contrast Media market in Europe is growing at a rapid rate. The government policies could be the explanation for the same. Contrast medium is a substance used to improve the contrast between liquids or structures within the body as part of medicinal imaging. This helps in improving the imaging of anatomical structures and organs by widening the contrast image. The growth of the contrast media or contrast operator market is guided by increasing interest in picture-guided diagnostics and strategies, growing mortality of constant illnesses, such as malignancy, and heart disease, gastrointestinal scatters, and by creating interest in picture-guided surgical methods.
Aging is a high-risk factor for several chronic diseases. Most of the developed and developing economies are experiencing an unprecedented and rapid increase in the percentage of elderly people with far-reaching health and economic consequences. Aging is an established risk factor for several chronic diseases, such as stroke, cardiovascular disease, arthritis and dementia, cancer. The diagnosis and treatment of these rising chronic diseases put significant pressures on the budgets of the National Healthcare System. Despite the importance of the issue, little is known about the true effect of aging on the prevalence and patterns of age-related chronic diseases and associated costs of Healthcare utilizing population data.
Based on Product Type, the market is segmented into Iodinated, Barium-based, Gadolinium-based and Microbubble. Based on Application, the market is segmented into Neurological disorders, Cancer, Cardiovascular disorders, Gastrointestinal disorders, Nephrological disorders, Musculoskeletal disorders and Other Applications. Based on Modality, the market is segmented into X-ray/CT, MRI and Ultrasound. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Bayer AG, General Electric (GE) Co. (GE Healthcare), The Guerbet Group, Lantheus Holdings, Inc., Bracco S.p.A., Trivitron Healthcare Pvt. Ltd., Nano Therapeutics Pvt. Ltd., Magnus Health, LLC (Veracross LLC), Imax Diagnostic Imaging Limited, and Daiichi Sankyo Company, Limited.
Scope of the Study
By Product Type
- Neurological disorders
- Cardiovascular disorders
- Gastrointestinal disorders
- Nephrological disorders
- Musculoskeletal disorders
- Other Applications
- Rest of Europe
- Bayer AG
- General Electric (GE) Co. (GE Healthcare)
- The Guerbet Group
- Lantheus Holdings, Inc.
- Bracco S.p.A.
- Trivitron Healthcare Pvt. Ltd.
- Nano Therapeutics Pvt. Ltd.
- Magnus Health, LLC (Veracross LLC)
- Imax Diagnostic Imaging Limited
- Daiichi Sankyo Company, Limited
Unique Offerings from KBV Research
- Exhaustive coverage
- Highest number of market tables and figures
- Subscription based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free